Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human Serv”

1,157 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,157
Index total 30,257
Page 35 / 49

Quick answer

This filtered view shows 1,157 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,157 results for “The United States of America, as represented by the Secretary, Department of Health and Human Serv” · 30,257 patents in full index Clear search

  1. US 9314532

    Drug delivery vehicle

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  2. US 9316646

    Anti-human ROR1 antibodies

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  3. US 9314448

    Method of inhibiting ABCG2 and other treatment methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  4. US 9308163

    Methods of treating and preventing diseases and disorders of the central nervous system

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  5. US 9309237

    HIV inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  6. US 9303044

    7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  7. US 9296790

    Methods and compositions for protein delivery

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 29, 2016 · Expires Mar 24, 2036

    granted

  8. US 9290512

    Activators of human pyruvate kinase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted

  9. US 9283233

    Method for on-demand contraception

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted

  10. US 9278090

    Methods of preventing the development of mucositis and related disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted

  11. US 9277748

    Agonist/antagonist compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted

  12. US 9278089

    Method of treating HCV infection with a small molecule CHK2 inhibitor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted

  13. US 9272023

    Use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  14. US 9273136

    Fully human anti-human NKG2D monoclonal antibodies

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  15. US 9273124

    Monoclonal antibodies that react with the capsule of Bacillus anthracis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  16. US 9273121

    Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  17. US 9266960

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted

  18. US 9266928

    Deletion of the beta 20-21 loop in HIV GP120 exposes the CD4 binding site for improved antibody binding and antibody induction

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted

  19. US 9259463

    Chlamydia vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted

  20. US 9243036

    Anti-microbial activity of synthetic peptides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted

  21. US 9238684

    SPANX-B polypeptides and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  22. US 9238069

    Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in cancer treatment

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  23. US 9238799

    Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  24. US 9238800

    Avian adenoassociated virus and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.